{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:11:57Z","timestamp":1793686317624,"version":"4.5.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40256-026-00794-9","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:58:16Z","timestamp":1777107496000},"page":"435-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration"],"prefix":"10.1007","volume":"26","author":[{"given":"Ce","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9125-3024","authenticated-orcid":false,"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"9","key":"794_CR1","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s11427-025-2948-y","volume":"68","author":"S Xu","year":"2025","unstructured":"Xu S, Liu Y, Zhu M, Chen K, Xu F, Liu Y. Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks. Sci China Life Sci. 2025;68(9):2739\u201354.","journal-title":"Sci China Life Sci"},{"key":"794_CR2","doi-asserted-by":"crossref","unstructured":"Banach M, Toth PP, Ahn H-J, Bielecka-Dabrowa A, Cicero AFG, Covic A, Dalakoti M, Escobar C, Fogacci F, Gaita D, Gaita L, J\u00f3\u017awiak J, Latkovskis G, Lewek J, Ntaios G, Okopie\u0144 B, Pe\u0107in I, Pella D, Penson PE, Proietti M, Sadowski J, Solnica B, Sosnowska B, Viigimaa M, Lip GYH. Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP). Progr Cardiovasc Dis. 2026;94:78\u2013110.","DOI":"10.1016\/j.pcad.2025.11.003"},{"issue":"1","key":"794_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/ATVBAHA.123.320065","volume":"44","author":"KJ Williams","year":"2024","unstructured":"Williams KJ. Eradicating atherosclerotic events by targeting early subclinical disease: it is time to retire the therapeutic paradigm of too much, too late. Arterioscler Thromb Vasc Biol. 2024;44(1):48\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"794_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41569-021-00589-2","volume":"19","author":"DM Fernandez","year":"2021","unstructured":"Fernandez DM, Giannarelli C. Immune cell profiling in atherosclerosis: role in research and precision medicine. Nat Rev Cardiol. 2021;19(1):43\u201358.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"794_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00395-025-01121-0","volume":"120","author":"K Iliodromitis","year":"2025","unstructured":"Iliodromitis K, Seyfarth M, Balogh Z, Bogossian H, Iliodromitis E, Triposkiadis F. Anti-inflammatory interventions in coronary artery disease: antipodal responses requiring targeted therapeutic strategies. Basic Res Cardiol. 2025;120(4):597\u2013618.","journal-title":"Basic Res Cardiol"},{"key":"794_CR6","doi-asserted-by":"publisher","first-page":"0089","DOI":"10.34133\/bmr.0089","volume":"28","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zhao L, Li J, Li H, Chen Y. Harnessing nanotechnology for gout therapy: colchicine-loaded nanoparticles regulate macrophage polarization and reduce inflammation. Biomater Res. 2024;28:0089.","journal-title":"Biomater Res"},{"key":"794_CR7","first-page":"68","volume":"84","author":"J Aldana-Bitar","year":"2024","unstructured":"Aldana-Bitar J, Golub IS, Moore J, Krishnan S, Verghese D, Manubolu VS, et al. Colchicine and plaque: a focus on atherosclerosis imaging. Prog Cardiovasc Dis. 2024;84:68\u201375.","journal-title":"Prog Cardiovasc Dis"},{"key":"794_CR8","doi-asserted-by":"publisher","first-page":"0089","DOI":"10.34133\/bmr.0089","volume":"28","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhao L, Li J, Li H, Zhang N. Harnessing nanotechnology for Gout therapy: colchicine-loaded nanoparticles regulate macrophage polarization and reduce inflammation. Biomater Res. 2024;28:0089.","journal-title":"Biomater Res"},{"key":"794_CR9","doi-asserted-by":"crossref","unstructured":"Aldana-Bitar J, Golub IS, Moore J, Krishnan S, Verghese D, Manubolu VS, Benzing T, Ichikawa K, Hamal S, Kianoush S, Anderson LR, Ramirez NR, Leipsic JA, Karlsberg RP, Budoff MJ. Colchicine and plaque: a focus on atherosclerosis imaging. Progr Cardiovasc Dis. 2024.","DOI":"10.1016\/j.pcad.2024.02.010"},{"issue":"11","key":"794_CR10","volume":"11","author":"F Ebrahimi","year":"2025","unstructured":"Ebrahimi F, Ebrahimi R, Beer M, Sch\u00f6nenberger CM, Ewald H, Briel M, et al. Colchicine for the secondary prevention of cardiovascular events. Cochrane Database Syst Rev. 2025;11(11):Cd014808.","journal-title":"Cochrane Database Syst Rev"},{"issue":"36","key":"794_CR11","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"key":"794_CR12","doi-asserted-by":"crossref","unstructured":"Maes L, Walsh C, Weimar C, Purroy F, Price C, Clarke B, Castro P, Czlonkowska A, Cuadrado-Godia E, Fischer U, Fonseca AC, Hill M. D, Jatuzis D, K\u00f5rv J, Kruuse C, Mikulik R, Nederkoorn PJ, Sztriha L, Thieme M, Kelly P, Lemmens R. Effect of colchicine for secondary prevention according to stroke subtype: a secondary analysis of the CONVINCE randomized trial. Int J Stroke. 2025.","DOI":"10.1177\/17474930251406818"},{"issue":"28","key":"794_CR13","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","volume":"42","author":"M Imazio","year":"2021","unstructured":"Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J. 2021;42(28):2745\u201360.","journal-title":"Eur Heart J"},{"key":"794_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003872","author":"J Bausson","year":"2024","unstructured":"Bausson J, Keller N, Von Hunolstein J-J, Sacrez M, Michel B, Gourieux B, et al. Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease. RMD Open. 2024. https:\/\/doi.org\/10.1136\/rmdopen-2023-003872.","journal-title":"RMD Open"},{"issue":"9","key":"794_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/eurjpc\/zwae355","volume":"32","author":"N Mohammadnia","year":"2025","unstructured":"Mohammadnia N, van Broekhoven A, Bax WA, Eikelboom JW, Mosterd A, Fiolet ATL, et al. The effects of colchicine on lipoprotein(a)- and oxidized phospholipid-associated cardiovascular disease risk. Eur J Prev Cardiol. 2025;32(9):758\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"794_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","volume":"135","author":"PC Robinson","year":"2022","unstructured":"Robinson PC, Terkeltaub R, Pillinger MH, Shah B, Karalis V, Karatza E, et al. Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. Am J Med. 2022;135(1):32\u20138.","journal-title":"Am J Med"},{"key":"794_CR17","unstructured":"Higgins JPT TJ, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from: https:\/\/training.cochrane.org\/handbook. Accessed 25 Feb 2025."},{"key":"794_CR18","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372:n71.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"15","key":"794_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"key":"794_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed). 2011;343:d5928.","journal-title":"BMJ (Clin Res Ed)"},{"key":"794_CR21","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clin Res Ed). 2019;366:l4898.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"4","key":"794_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"794_CR23","unstructured":"Sch\u00fcnemann HJ, Visit GE, Glasziou P, Akl EA, Skoetz N, Guyatt GH., Chapter 14: completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence [last updated May 2025]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA ,editors. Cochrane Handbook for systematic reviews of interventions version 6.5.1. Cochrane, 2024."},{"issue":"2","key":"794_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363.","journal-title":"Biometrics"},{"issue":"7414","key":"794_CR25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"4","key":"794_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61(4):404\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"794_CR27","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"26","key":"794_CR28","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"issue":"20","key":"794_CR29","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"DC Tong","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, et al. Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial. Circulation. 2020;142(20):1890\u2013900.","journal-title":"Circulation"},{"issue":"10448","key":"794_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","volume":"404","author":"P Kelly","year":"2024","unstructured":"Kelly P, Lemmens R, Weimar C, Walsh C, Purroy F, Barber M, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial. Lancet. 2024;404(10448):125\u201333.","journal-title":"Lancet"},{"key":"794_CR31","volume":"385","author":"J Li","year":"2024","unstructured":"Li J, Meng X, Shi FD, Jing J, Gu HQ, Jin A, et al. Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial. BMJ (Clin Res Ed). 2024;385:e079061.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"7","key":"794_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa2405922","volume":"392","author":"SS Jolly","year":"2025","unstructured":"Jolly SS, d\u2019Entremont MA, Lee SF, Mian R, Tyrwhitt J, Kedev S, et al. Colchicine in acute myocardial infarction. N Engl J Med. 2025;392(7):633\u201342.","journal-title":"N Engl J Med"},{"issue":"16","key":"794_CR33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","volume":"61","author":"S Deftereos","year":"2013","unstructured":"Deftereos S, Giannopoulos G, Raisakis K, Kossyvakis C, Kaoukis A, Panagopoulou V, et al. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J Am Coll Cardiol. 2013;61(16):1679\u201385.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"794_CR34","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","volume":"132","author":"S Deftereos","year":"2015","unstructured":"Deftereos S, Giannopoulos G, Angelidis C, Alexopoulos N, Filippatos G, Papoutsidakis N, et al. Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study. Circulation. 2015;132(15):1395\u2013403.","journal-title":"Circulation"},{"issue":"4","key":"794_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","volume":"13","author":"B Shah","year":"2020","unstructured":"Shah B, Pillinger M, Zhong H, Cronstein B, Xia Y, Lorin JD, et al. Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial. Circ Cardiovasc Interv. 2020;13(4):e008717.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6\u20137","key":"794_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","volume":"110","author":"M Akodad","year":"2017","unstructured":"Akodad M, Lattuca B, Nagot N, Georgescu V, Buisson M, Cristol JP, et al. COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response. Arch Cardiovasc Dis. 2017;110(6\u20137):395\u2013402.","journal-title":"Arch Cardiovasc Dis"},{"key":"794_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","volume":"215","author":"T Hennessy","year":"2019","unstructured":"Hennessy T, Soh L, Bowman M, Kurup R, Schultz C, Patel S, et al. The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction. Am Heart J. 2019;215:62\u20139.","journal-title":"Am Heart J"},{"issue":"13","key":"794_CR38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","volume":"150","author":"M Yu","year":"2024","unstructured":"Yu M, Yang Y, Dong SL, Zhao C, Yang F, Yuan YF, et al. Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial. Circulation. 2024;150(13):981\u201393.","journal-title":"Circulation"},{"issue":"1","key":"794_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","volume":"33","author":"NC Raju","year":"2012","unstructured":"Raju NC, Yi Q, Nidorf M, Fagel ND, Hiralal R, Eikelboom JW. Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial. J Thromb Thrombolysis. 2012;33(1):88\u201394.","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"794_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","volume":"144","author":"N Mewton","year":"2021","unstructured":"Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, et al. Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation. 2021;144(11):859\u201369.","journal-title":"Circulation"},{"issue":"7","key":"794_CR41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","volume":"19","author":"JH O'Keefe Jr","year":"1992","unstructured":"O\u2019Keefe JH Jr, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 1992;19(7):1597\u2013600.","journal-title":"J Am Coll Cardiol"},{"key":"794_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells15010072","author":"DM Brie","year":"2025","unstructured":"Brie DM, Morno\u0219 C, Adam O, T\u00eerziu A, Popescu R, Brie AD. Inflammatory mechanisms in acute coronary syndromes: from pathophysiology to therapeutic targets. Cells. 2025. https:\/\/doi.org\/10.3390\/cells15010072.","journal-title":"Cells"},{"issue":"4","key":"794_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/antiox12040960","volume":"12","author":"H Zhou","year":"2023","unstructured":"Zhou H, Khan D, Gerdes N, Hagenbeck C, Rana M, Cornelius JF, et al. Colchicine protects against ethanol-induced senescence and senescence-associated secretory phenotype in endothelial cells. Antioxidants. 2023;12(4):960.","journal-title":"Antioxidants"},{"issue":"1","key":"794_CR44","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1038\/s41598-021-91409-7","volume":"11","author":"GJ Pennings","year":"2021","unstructured":"Pennings GJ, Reddel CJ, Traini M, Campbell H, Chen V, Kritharides L. Colchicine inhibits ROS generation in response to glycoprotein VI stimulation. Sci Rep. 2021;11(1):11965.","journal-title":"Sci Rep"},{"issue":"5","key":"794_CR45","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/cpt.3394","volume":"116","author":"H Tercan","year":"2024","unstructured":"Tercan H, van Broekhoven A, Bahrar H, Opstal T, Cossins BC, Rother N, et al. The effect of low-dose colchicine on the phenotype and function of neutrophils and monocytes in patients with chronic coronary artery disease: a double-blind randomized placebo-controlled cross-over study. Clin Pharmacol Ther. 2024;116(5):1325\u201333.","journal-title":"Clin Pharmacol Ther"},{"issue":"19","key":"794_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036701","volume":"13","author":"N Talmor","year":"2024","unstructured":"Talmor N, Pillinger MH, Xia Y, Leonard A, Curovic F, Shah B. Neutrophil activation and adhesiveness in coronary artery disease: results from the COLCHICINE-PCI biomarker substudy. J Am Heart Assoc. 2024;13(19):e036701.","journal-title":"J Am Heart Assoc"},{"issue":"2 Pt 2","key":"794_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","volume":"11","author":"K Vaidya","year":"2018","unstructured":"Vaidya K, Arnott C, Mart\u00ednez GJ, Ng B, McCormack S, Sullivan DR, et al. Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study. JACC Cardiovasc Imaging. 2018;11(2 Pt 2):305\u201316.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"23","key":"794_CR48","first-page":"1156","volume":"111","author":"ATL Fiolet","year":"2025","unstructured":"Fiolet ATL, Lin A, Kwiecinski J, Tutein Nolthenius J, McElhinney P, Grodecki K, et al. Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial. Heart (Br Card Soc). 2025;111(23):1156\u201363.","journal-title":"Heart (Br Card Soc)"},{"issue":"3","key":"794_CR49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cvr\/cvae191","volume":"121","author":"PJ Psaltis","year":"2025","unstructured":"Psaltis PJ, Nguyen MT, Singh K, Sinhal A, Wong DTL, Alcock R, et al. Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction. Cardiovasc Res. 2025;121(3):468\u201378.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"794_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2025.100726","volume":"4","author":"M Yellen","year":"2025","unstructured":"Yellen M, Modi R, Yao R, Storozuk T, Tanager K, Reddy K. Drug-induced dysphagia and diarrhea: a case of colchicine toxicity. Gastro Hep Adv. 2025;4(10):100726.","journal-title":"Gastro Hep Adv"},{"issue":"2","key":"794_CR51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003183","volume":"14","author":"MP Dub\u00e9","year":"2021","unstructured":"Dub\u00e9 MP, Legault MA, Lema\u00e7on A, Lemieux Perreault LP, Fouodjio R, Waters DD, et al. Pharmacogenomics of the efficacy and safety of colchicine in COLCOT. Circ Genom Precis Med. 2021;14(2):e003183.","journal-title":"Circ Genom Precis Med"},{"issue":"655","key":"794_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3399\/bjgp17X688993","volume":"67","author":"E Roddy","year":"2017","unstructured":"Roddy E, Mallen CD. Colchicine in overdose. Br J Gen Pract. 2017;67(655):61.","journal-title":"Br J Gen Pract"},{"issue":"653","key":"794_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3399\/bjgp16X688333","volume":"66","author":"G Lloyd","year":"2016","unstructured":"Lloyd G. Colchicine in overdose. Br J Gen Pract. 2016;66(653):605.","journal-title":"Br J Gen Pract"},{"issue":"18","key":"794_CR54","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/eurjpc\/zwad221","volume":"30","author":"PM Burger","year":"2023","unstructured":"Burger PM, Dorresteijn JAN, Fiolet ATL, Koudstaal S, Eikelboom JW, Nidorf SM, et al. Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease. Eur J Prev Cardiol. 2023;30(18):1950\u201362.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"794_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-025-00515-2","volume":"10","author":"P Jord\u00e0","year":"2025","unstructured":"Jord\u00e0 P, Lai Y, Jeuken A, Lemieux Perreault LP, Goulet E, Lahrouchi N, et al. Genetic analyses across cardiovascular traits: leveraging genetic correlations to empower locus discovery and prediction in common cardiovascular diseases. npj Genom Med. 2025;10(1):65.","journal-title":"npj Genom Med"},{"issue":"9","key":"794_CR56","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1023\/A:1018883731556","volume":"42","author":"GN Verne","year":"1997","unstructured":"Verne GN, Eaker EY, Davis RH, Sninsky CA. Colchicine is an effective treatment for patients with chronic constipation: an open-label trial. Dig Dis Sci. 1997;42(9):1959\u201363.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"794_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/BF01393768","volume":"27","author":"M Ehrenfeld","year":"1982","unstructured":"Ehrenfeld M, Levy M, Sharon P, Rachmilewitz D, Eliakim M. Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial mediterranean fever). Dig Dis Sci. 1982;27(8):723\u20137.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"794_CR58","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1365-2982.2008.01245.x","volume":"21","author":"CE Bernard","year":"2009","unstructured":"Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, et al. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009;21(7):746-e46.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"794_CR59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ageing\/afh040","volume":"33","author":"JL Madsen","year":"2004","unstructured":"Madsen JL, Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing. 2004;33(2):154\u20139.","journal-title":"Age Ageing"},{"issue":"12","key":"794_CR60","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.41328","volume":"4","author":"R Diaz","year":"2021","unstructured":"Diaz R, Orlandini A, Castellana N, Caccavo A, Corral P, Corral G, et al. Effect of colchicine vs usual care alone on intubation and 28-day mortality in patients hospitalized with COVID-19: a randomized clinical trial. JAMA Netw Open. 2021;4(12):e2141328.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"794_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","volume":"23","author":"MS Diamond","year":"2022","unstructured":"Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nat Immunol. 2022;23(2):165\u201376.","journal-title":"Nat Immunol"},{"issue":"5","key":"794_CR62","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14(5):454\u201360.","journal-title":"Nat Immunol"},{"key":"794_CR63","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet Respir Med. 2021;9(12):1419\u201326.","DOI":"10.1016\/S2213-2600(21)00435-5"},{"issue":"12","key":"794_CR64","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","volume":"122","author":"A Grebe","year":"2018","unstructured":"Grebe A, Hoss F, Latz E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis. Circ Res. 2018;122(12):1722\u201340.","journal-title":"Circ Res"},{"issue":"8","key":"794_CR65","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"794_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355\u201362.","journal-title":"Nat Rev Immunol"},{"key":"794_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-086393","volume":"392","author":"MD Russell","year":"2026","unstructured":"Russell MD, Schaffer A, Bechman K, Gibson M, Massey J, Higgins R, et al. Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the COVID-19 pandemic: population based cohort study in England using OpenSAFELY. BMJ. 2026;392:e086393.","journal-title":"BMJ"},{"issue":"1","key":"794_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-103884","volume":"16","author":"J Prashar","year":"2026","unstructured":"Prashar J, Hillman T, Wall EC, Sarna A, Mi E, Bell R, et al. Trajectory, healthcare utilisation and recovery in 3590 individuals with long COVID: a 4-year prospective cohort analysis. BMJ Open. 2026;16(1):e103884.","journal-title":"BMJ Open"},{"issue":"1","key":"794_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CRD.0000000000000654","volume":"34","author":"MW McMaster","year":"2026","unstructured":"McMaster MW, Dey S, Fishkin T, Wang A, Frishman WH, Aronow WS. The impact of long COVID-19 on the cardiovascular system. Cardiol Rev. 2026;34(1):11\u20138.","journal-title":"Cardiol Rev"},{"key":"794_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf278","author":"JC Dos Santos","year":"2026","unstructured":"Dos Santos JC, Netea MG, Riksen NP. Trained immunity links cardiovascular disease and COVID-19. Cardiovasc Res. 2026. https:\/\/doi.org\/10.1093\/cvr\/cvaf278.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"794_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00674-7","volume":"11","author":"JE Wilson","year":"2025","unstructured":"Wilson JE, Gurdasani D, Helbok R, Ozturk S, Fraser DD, Filipovi\u0107 SR, et al. COVID-19-associated neurological and psychological manifestations. Nat Rev Dis Primers. 2025;11(1):91.","journal-title":"Nat Rev Dis Primers"},{"key":"794_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2025.107706","volume":"184","author":"RTH Ho","year":"2026","unstructured":"Ho RTH, Lo TLT, Fong TCT, Jiang D, Kwok JYY, Yeung DY, et al. The mediating role of loneliness between psychosocial and physiological well-being in older adults. Psychoneuroendocrinology. 2026;184:107706.","journal-title":"Psychoneuroendocrinology"},{"key":"794_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010433","author":"M Stojanovic","year":"2025","unstructured":"Stojanovic M, Djuric M, Nenadic I, Bojic S, Andrijevic A, Popovic A, et al. Vascular complications of long COVID-from endothelial dysfunction to systemic thrombosis: a systematic review. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms27010433.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"794_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-026-07651-w","volume":"26","author":"C Cardemil","year":"2026","unstructured":"Cardemil C, Salinas Fredricson A, Rasmusson L, Dimberg L. The effect of the COVID-19 pandemic on orthognathic surgery in Sweden\u2014a registry-based study. BMC Oral Health. 2026;26(1):107.","journal-title":"BMC Oral Health"},{"key":"794_CR75","doi-asserted-by":"crossref","unstructured":"Wadhera RK, Waken RJ, Wang F, Figueroa JF, Avula KC, Orav EJ, Epstein AM, Joynt Maddox KE. Hospitalizations and mortality among medicare beneficiaries at cardiovascular risk: disruptions and recovery from the COVID-19 pandemic. J Am Coll Cardiol. 2026.","DOI":"10.1016\/j.jacc.2025.11.033"},{"key":"794_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2025.101891","volume":"33","author":"AM Ipekci","year":"2026","unstructured":"Ipekci AM, Filsinger M, Buitrago-Garcia D, Kobler Betancourt CI, Liwanag HJ, Frahsa A, et al. Polarization and health-related behaviors and outcomes during the COVID-19 pandemic: a systematic review. SSM Popul Health. 2026;33:101891.","journal-title":"SSM Popul Health"},{"key":"794_CR77","volume":"34","author":"LDS Araujo","year":"2026","unstructured":"Araujo LDS, Ferrari KLP, Tonetto P, Zanetti D, Dessotte CAM, Dantas RAS. Self-care and fatigue in individuals hospitalized with decompensated heart failure during the covid-19 pandemic: a cross-sectional study. Rev Lat Am Enfermagem. 2026;34:e4617.","journal-title":"Rev Lat Am Enfermagem"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-026-00794-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00794-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:02:44Z","timestamp":1781182964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-026-00794-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s40256-026-00794-9","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bo Li, Xiaodong Jin, Zhe Dong, Beibei Song, and Ce Bian made substantial contributions to the conception or design of the work. Ce Bian, Xin-Xin Liu, and Qi Shen made substantial contributions to the acquisition, analysis, and interpretation of data for the work. Bo Li, Ce Bian, and Xin-Xin Liu drafted the work or reviewed it critically for important intellectual content. Bo Li and Xin-Xin Liu gave given final approval of the version to be published. Ce Bian, Qi Shen, Mengjun Zhou, and Zhexue Ren agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"All authors declare that they have no potential conflicts of interest that might be relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The datasets used and\/or analyzed during the current systematic review and meta-analysis are available from the corresponding author upon reasonable request. All data were extracted from previously published studies identified through systematic searches of PubMed, Embase, and the Cochrane Central Register of Controlled Trials. The study protocol was registered in the PROSPERO international prospective register of systematic reviews (registration number: CRD42024623329). Data used in the meta-analysis can be made available upon reasonable request to the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}